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SUMMARY – Oxidative stress is defined as imbalance between the production and destruction 
of reactive oxygen species. The aim of this study was to investigate whether resveratrol could protect 
human endothelial cells against hydrogen peroxide damage in vitro. In this in vitro study on human 
coronary endothelial cells, the effects of resveratrol on the glutathione content in human coronary 
endothelial cells in vitro were evaluated with high performance liquid chromatography. The effects of 
resveratrol on protein expression of the glutamate cysteine ligase, glutathione peroxidase and glutathio-
ne reductase enzymes were evaluated with the Western blot method. Resveratrol increased the reduced 
glutathione contents significantly (p<0.05). Resveratrol increased protein expression of the glutamate 
cysteine ligase, glutathione peroxidase-1 and glutathione reductase enzymes (p<0.05). All data sup-
ported each other and suggested that resveratrol had a protective effect against human coronary artery 
endothelial cell damage. It is thought that these results could pave the way to the new therapeutic 
approaches to protect against oxidative stress that develops in cardiovascular diseases.
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Introduction
The endothelial cells localized between the blood 
and vascular smooth muscle cells play a role in the 
secretion of many vasoactive materials, in platelet ag-
gregation, and in the control of vascular structure1. 
Because of its position in the blood vessels, the en-
dothelial layer works as a barrier between the blood 
and vascular smooth muscle cells, and functional 
integrity of the endothelium is important to prevent 
vascular leakage and atherosclerosis formation2,3. 
Under physiologic conditions, the formation and 
elimination of reactive oxygen species (ROS) are in 
balance. Increase in the oxidant enzyme activity and/
or decrease in the antioxidant enzyme activity lead to 
oxidative stress. Oxidative stress plays an important 
role in cardiovascular diseases, cancer, neurologic dis-
eases, diabetes, and aging4. Oxidative stress is char-
acterized by increase in endogenous reactive oxygen 
products such as hydrogen peroxide and superoxide. 
ROS include very bioactive, short living molecules 
originating from the reduction of molecular oxygen5. 
Some of the common ROS are hydrogen peroxide 
(H2O2), superoxide anion (O2-), and hydroxyl radical 
(OH)6. H2O2 does not possess non-coupled electrons 
and is less reactive than many ROS types7. Besides 
activating many signal pathways in low pathophysi-
ological concentrations (nano-micromolar), in high 
concentrations by reacting with heavy metals H2O2 
produces the hydroxyl radical which oxidizes proteins 
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and lipids, and causes fractures in DNA strands. High 
hydrogen peroxide level generally causes endothelial 
functional loss and/or cytotoxicity8.
Enzymatic antioxidant protection includes super-
oxide dismutase, glutathione peroxidase and catalase. 
Non-enzymatic antioxidants are ascorbic acid, a-to-
copherol, glutathione, carotenoids, flavonoids, stilbene 
and others. There is balance between the intracellular 
antioxidant level and efficiency under normal condi-
tions. This balance is necessary for viability and health 
of the body9-12. Resveratrol (3,4’,5-trihydroxy-trans-
stilbene) is a phytoalexin and polyphenolic compound 
that can be found in the skin and seeds of grapes 
and red wine. It has antioxidant, anti-inflammatory, 
and anticarcinogenic effects13,14. Resveratrol has been 
shown to exert its antioxidant effects via two different 
cytoprotective mechanisms; it directly scavenges free 
radicals (i.e. hydroxyl radicals and superoxide anion) 
and increases the activity of certain antioxidant and 
cytoprotective enzymes15.
Glutathione is a non-protein thiol compound in-
volved in cell protection from ROS and free radicals, 
and maintains the cellular redox state. Glutathione is 
present in mammalian cell types at millimolar con-
centrations and plays a role in detoxification of xeno-
biotics, transportation of amino acids, stabilization of 
cell membranes, and synthesis of proteins and DNA16-
18. Glutathione peroxidases (GPxs), which contain 
selenocysteine at the active site, protect the cells from 
oxidative stress by reducing H2O2 and a wide range 
of organic hydroperoxide substrates. Glutathione 
peroxidase-1 (GPx-1, EC 1.11.1.9) is known as cel-
lular or cytosolic form, and being the most abundant 
isoform within the eukaryotic cells, is a major intra-
cellular antioxidant enzyme19,20. Glutamate cysteine 
ligase (GCL, EC 6.3.2.2), which is a rate limiting 
enzyme in de novo synthesis of glutathione, was previ-
ously known as γ-glutamyl cysteine synthase. GCL is 
a heterodimer which consists of heavy subunit, cata-
lytic subunit (GCLC) and light subunit, regulatory 
subunit (GLCLR). The heavy subunit contains sub-
strate binding sites and the light subunit regulates the 
affinity of the heavy subunit for substrates and inhibi-
tors21-23. Glutathione reductase (GR, EC 1.6.4.2) is a 
homodimer which is bound by disulfide bond and is 
found in the cytoplasm and mitochondria. Glutathi-
one reductase is a flavin adenine dinucleotide (FAD) 
containing oxidoreductase belonging to the pyridine 
nucleotide disulfide family. The activated enzyme is 
composed of two subunits and each one has binding 
sites for FAD, NADPH and oxidized glutathione 
(GSSG). This enzyme converts oxidized glutathione 
to its reduced form24. In the literature, various injury 
models with rat cardiomyocytes25, rat aorta smooth 
muscle cells26 and bovine aorta endothelial cells16 were 
used to investigate the protective effect mechanisms 
of resveratrol in vitro. However, there are no reports 
on the use of in vitro oxidative injury model of hu-
man coronary artery endothelial cells. Moreover, the 
effect of oxidative stress on protein expression of the 
glutamate cysteine ligase, glutathione peroxidase and 
glutathione reductase enzymes, which all work in the 
glutathione cycle, has not yet been evaluated.
In this study, we used a hydrogen peroxide injury 
model optimized for in vitro human coronary artery 
endothelial cells and investigated the possible ef-
fects of resveratrol by Western blotting of glutamate 
cysteine ligase, glutathione peroxidase-1 and glutathi-
one reductase.
Materials and Methods
Human coronary artery endothelial cell culture and 
materials
Human coronary artery endothelial cells (HCAE 
cells) were obtained from Clonetics Lonza USA (CC-
2585). HCAE cells were grown in the culture medium 
(EGM-2MV Bullet kit, Clonetics Lonza USA, CC-
3202). EGM-2MV bullet kit is composed of EBM-2 
(CC-3156) and EGM–2 MV growth factors (CC-
4147). The reagent pack was purchased from Cam-
brex [(one reagent pack containing trypsin/EDTA, 
trypsin neutralizing solution, HEPES buffered saline 
solution (CC-5034)] and cell culture was performed 
according to the manufacturer’s instructions. Seeding 
density was 5000 cells/cm2 in HCAE cells. HCAE 
cells were maintained in the endothelial growth me-
dium supplemented with 25% fetal bovine serum, 
hydrocortisone, hFGF-B, VEGF, R3-IGF-1, ascorbic 
acid, hEGF and GA-1000 (Clonetics). The cells were 
incubated in a humidified atmosphere containing 5% 
CO2 at 37 °C. The medium was changed every other 
day and passaged every 5-9 days. In all experiments, 
HCAE cells were used in 5th-7th passages.
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In vitro experiments
We used the oxidative injury model optimized in 
our previous studies as described below27. The opti-
mum time and concentration of hydrogen peroxide, 
which caused 30%-40% injury in in vitro human cor-
onary artery endothelial cells, were determined as 750 
µM; 1 hour. Using this model, we selected 50 µM for 
the resveratrol concentration to study its effects.
In this study, the cells were incubated with 50 µM 
resveratrol for 24 hours and then with 750 µM H2O2 
for 1 hour. At the end of the incubation period, cell 
lysates were prepared. We evaluated reduced glutathi-
one (GSH), oxidized glutathione (GSSG) and gluta-
mate-cysteine ligase, glutathione peroxidase-1, gluta-
thione reductase enzymes to investigate the protective 
effect of resveratrol during hydrogen peroxide injury. 
Glutathione level was determined with high perfor-
mance liquid chromatography (HPLC) and enzyme 
expression with Western blotting. After concentrat-
ing the cells by 70%-80%, four groups were formed: 
control, H2O2 group, resveratrol group and resveratrol 
+ H2O2 group. Triple group analysis was used for the 
glutathione, glutamate-cysteine ligase, glutathione 
peroxidase and glutathione reductase enzymes. Each 
experiment was repeated three times in order to stan-
dardize the process. The study protocol was approved 
by the local Research Ethics Committee of Dokuz 
Eylul University School of Medicine.
Measurement of cellular reduced and oxidized 
glutathione
Intracellular contents of GSH and GSSG were 
determined using HPLC. The cells were first scraped 
with cold phosphate buffer solution (PBS) and centri-
fuged at 300 g for 7 min at 4 °C and then cell lysates 
were prepared, as shown in the Preparation of cell 
lysate section. The supernatants containing cytosolic 
proteins were used for protein content determination 
by the bicinchoninic acid (BCA) method (Thermo, 
Cat No: BCA, Protein assay kits, 23225, Rockford, 
USA). Then, the supernatants containing cytosolic 
proteins (100 µL) were deproteinized by adding 400 
mL of 6% metaphosphoric acid (MPA) and centri-
fuged for 7 min at 10 000 g at 4 °C. The supernatants 
were stored at -80 °C until use. To determine reduced 
glutathione (GSH), 100 mL of MPA, 500 mM sodi-
um phosphate, pH 7.00 were added to the supernatant 
to neutralize and dilute it. Neutralized samples were 
derived with 100 µL of ortho-phthalaldehyde (OPA) 
solution and then held for 5 min at room tempera-
ture; for neutralization 800 mL of 500 mM sodium 
phosphate was added to the product. For analysis of 
reduced glutathione, five microliters were injected 
into the HPLC system. For total glutathione (GSHt) 
determination, GSSG was reduced with dithiothre-
itol (DTT) and then protein precipitation was carried 
out. For this purpose, samples were treated with 100 
µL of 25 mM DTT solution and 50 µL 0.1 M Tris 
buffer, pH 8.5 and then stored for 30 min at 4 °C. 
Samples (100 µL) were deproteinized by adding 400 
mL of 6% MPA and centrifuged for 7 min at 10 000 g 
at 4 °C and the supernatants were removed. Derivati-
zation procedure for the supernatants was performed 
as described above. Oxidized glutathione values were 
calculated by subtracting GSH values from total GSH 
and then dividing into two. The results were expressed 
as nmol/mg protein17.
Preparation of cell lysates and determination of 
protein expression of glutamate cysteine ligase, 
glutathione peroxidase-1 and glutathione reductase 
with Western blotting
HCAE cells were treated with 50 µM resvera-
trol for 24 hours and then incubated for one hour at 
750 µM H2O2. At the end of the incubation period, 
cells were scraped, centrifuged at 300 g for 7 min at 
4 °C; then cell lysates were prepared: the supernatants 
were washed with ice-cold PBS, again centrifuged at 
1500 rpm for 5 min, 200 µL lysis buffer was added 
( NP-40 1%, 1 M Tris pH 7.4, 3 M NaCl, 20 mM 
EDTA, Protease inhibitors (Complete-mini protease 
inhibitors, Roche Diagnostics GmbH) and after in-
cubating in an ice bath for 10 min, vortex-mixing was 
performed for 30 sec. To collect the supernatants con-
taining cytosolic proteins samples were centrifuged at 
10 000 g for 10 min. Protein concentrations in the 
supernatants were determined by BCA protein assay. 
Proteins in the cell lysate supernatants were analyzed 
in all samples using the BCA assay kit according to 
the manufacturer’s instructions28. The supernatants 
were used to analyze expression of the glutathione and 
glutamate cysteine ligase, glutathione peroxidase-1 
and glutathione reductase enzymes29. 
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Cell lysates were prepared as described above. 
Total protein concentration was determined by the 
BCA assay. Total cell lysate (40 µg) was mixed with 
sample buffer (25 mM Tris HCl, 5% SDS, 2-mercap-
toethanol 2%, glycerol %10, bromphenol blue 0.002%) 
and then incubated for 5 min at 95 °C. Samples were 
loaded on 10% SDS-separating and 4% stacking poly-
acrylamide gel. Then, the proteins were transferred on 
polyvinylidene difluoride (PVDF) membrane for 2 h 
at 200 mA. After blocking for 30 min with nonfat 
dry milk in PBS containing NP-40 (for glutamate 
cysteine ligase, glutathione peroxidase-1, glutathione 
reductase and actin; 4%, 3%, 5%, 3%, respectively), 
the PVDF membrane was incubated overnight with 
polyclonal rabbit antibody [glutamate cysteine ligase 
(Santa Cruz, sc-22667), glutathione peroxidase-1 
(Santa Cruz, sc-22145), glutathione reductase (San-
ta Cruz, sc-32408) and actin (Santa Cruz, sc-1615); 
1:500, 1:200, 1:500, 1:500 in blocking buffer, respec-
tively] at +4 ºC.
Then the PVDF membrane was washed three times 
with 10% PBS containing 0.05% NP-40. The PVDF 
membrane was incubated with donkey anti-goat IgG-
Horseradish Peroxidase Conjugated Affinity Purified 
Antibody (Santa Cruz, sc-2020) for one hour (gluta-
mate cysteine ligase, glutathione peroxidase-1, gluta-
thione reductase and actin, 1:3500, 1:3500, 1:5000, 
1:3500 in blocking buffer, respectively). The PVDF 
membrane was washed three times with 10% PBS 
containing 0.05% NP-40. The transferred proteins 
were incubated with ECL substrate solution (Amer-
sham Pharmacia Biotech, Piscataway, NJ, USA) for 1 
min according to the manufacturer’s instructions and 
then visualized with an x-ray film. The intensity of the 
bands was analyzed using the Quantity One software 
(BIORAD). β-Actin was used to normalize the load-
ing variability29. 
Statistical analysis
All experiments were repeated three times. All 
data were expressed as means ± SD. One way analysis 
of variance (ANOVA) was employed for comparison 
of significant differences among groups. The value of 
p≤0.05 was considered statistically significant. 
Results
Resveratrol prevents hydrogen peroxide-induced 
glutathione decrease in HCAE cells
H2O2 (at 750 µM) decreased the reduced glutathi-
one content significantly after 1 hour in HCAE cells; 
on the contrary, resveratrol increased the reduced 
glutathione content. Also, resveratrol (at 50 µM, 24 
hours) per se significantly increased the reduced glu-
tathione content compared to control group (p<0.05) 
(Fig. 1A).
On the other hand, H2O2 (at 750 µM) increased 
the oxidized glutathione content significantly after 1 
hour (p<0.05). There was no significant effect of res-
veratrol on the oxidized glutathione content (p>0.05) 
(Fig. 1B).
Fig. 1. Effect of resveratrol on reduced and oxidized glutathione contents. Cells were treated with 750 µM resveratrol 
for 24 hours and then with H2O2 for 1 hour. Glutathione content was measured by HPLC; (A) resveratrol increased the 
reduced glutathione content (p<0.05); (B) no effect of resveratrol was observed on oxidized glutathione content. Data 
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Resveratrol induces glutamate-cysteine ligase, 
glutathione peroxidase-1 and glutathione reductase 
protein expression in HCAE cells
Western blot analysis was performed to determine 
the resveratrol-induced changes in glutathione-related 
enzymes of the human coronary artery endothelial 
cells. Representative blots and values of densitometric 
analysis of the blots are shown in Fig. 2A-2C. Res-
veratrol up-regulated glutamate cysteine ligase, gluta-
thione reductase and glutathione peroxidase-1 protein 
expression in HCAE cells (p<0.05). β-Actin was used 
as the loading control. 
Discussion
Oxidative stress is characterized by increased 
endogenous production of ROS such as superoxide 
and hydrogen peroxide, and changes the structure 
and function of vascular endothelial cells. Oxidative 
stress plays an important role in the pathogenesis of 
cardiovascular diseases, cancer, neurologic diseases, 
Fig. 2. Effect of resveratrol on HCAE cell damage induced 
by hydrogen peroxide in vitro. Representative bands from 
Western blots showing protein expression of GCLC (A), 
GPx-1 (B) and GR (C) and bar graphs of densitometric 
values. HCAE cells were treated with 50 µM resvera-
trol for 24 hours after one hour of H2O2 damage and then 
the cells were lysed and Western blotting was performed. 
Resveratrol induced glutamate-cysteine ligase, glutathione 
peroxidase-1 and glutathione reductase expression signifi-
cantly. The values were expressed as mean ± SD of 3 sepa-
rate experiments (p<0.05). 
diabetes, aging, and many other diseases. Therefore, 
removal of excess ROS or suppression of their produc-
tion with antioxidants is effective in preventing oxida-
tive cell death. Resveratrol, which is present in high 
levels in the grapes, red wine, peanuts, cranberries, 
etc., has the potential to capture ROS4,30,31. Resvera-
trol has two different cell protective mechanisms for 
antioxidation: it captures free radicals directly (hy-
droxyl radical, superoxide anion radical) and its an-
tioxidant capacity is due to the balance between the 
hydroxyphenolic groups and electron delocalization. 
It shows other antioxidant effects by increasing the 
cell protective and antioxidant enzyme levels15,25,32.
In this study, glutamate-cysteine ligase, glutathi-
one peroxidase and glutathione reductase enzymes in 
HCAE cells were evaluated after treating for 24 hours 
with 50 µM resveratrol and then incubating for 1 hour 
with 750 µM, H2O2. When compared with control 
group, the reduced glutathione level decreased sig-
nificantly in the H2O2 group (p<0.05) and increased 
significantly when compared with resveratrol + H2O2 
group (p<0.05) (Fig. 1A). Resveratrol had no effect 
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on the oxidized glutathione levels (p>0.05) (Fig. 1B). 
Normally, the reduced glutathione level in the cells 
is regulated by two mechanisms: the synthesis rate 
and the extracellular export. GSH level is affected 
by cellular thiol balance changes or various agents18. 
The vast majority of intracellular glutathione (>98%) 
includes cytosol and a small amount of the nucleus re-
duced form (GSH) of glutathione conjugates (GS-R), 
mercaptides [Cr, Cu (I), Cu (II), Se, Zn], thioether, 
thioester and oxidized disulfide dimer forms (GSSG). 
As a powerful reductive agent, glutathione supplies 
protons or acts as a nucleophilic conjugate cofactor for 
the antioxidant pathways. GSH is transformed to oxi-
dized glutathione (GSSG), which is an electron do-
nor and reduces free radicals. GSH captures reactive 
products such as reactive oxygen and nitrogen prod-
ucts. GSH gives electrons and directly deactivates 
superoxide anion, hydroxyl radical, peroxynitrite and 
singlet oxygen. Also, glutathione detoxifies hydroper-
oxide, peroxynitrite and lipid peroxides by catalyzing 
glutathione peroxidase and peroxiredoxin reactions33. 
In our study, when the findings of reduced gluta-
thione and oxidized glutathione, which are the major 
components of oxidative stress and antioxidant bal-
ance, were compared, an increase in oxidized glu-
tathione to correspond to a decrease in the level of 
reduced glutathione was not observed during treat-
ment with H2O2 (p>0.05). This may be explained 
by the possibility that reduced glutathione may have 
been transformed into glutathione conjugates rather 
than into oxidized glutathione. In our study, we de-
termined a decrease in the intracellular glutathione 
level in the damage model created by hydrogen perox-
ide. This may be due to the fact that GSH moved out 
of the cell, formed glutathione-S-conjugates, or was 
oxidized to GSSG. Subsequently, GSSG is reduced to 
GSH by NADPH dependent glutathione reductase.
Resveratrol and resveratrol + hydrogen peroxide 
groups showed significant increase in intracellular 
GSH (p<0.05). Resveratrol stimulates the increase in 
the intracellular GSH pool. This is directly due to the 
intracellular effect of resveratrol because resveratrol is 
removed before treating the cells with hydrogen per-
oxide. Preincubation with resveratrol increased the 
GCLC protein expression. It has been suggested that 
resveratrol increases GSH level via GCLC induction. 
On the other hand, the increase in cellular GSH con-
centration increases the glutathione peroxidase protein 
expression. Furthermore, the increase of glutathione 
reductase protein expression by resveratrol leads to in-
creased GSH formation from GSSG, produced during 
GPx-catalyzed reduction of H2O2 in HCAE cells.
In our study, resveratrol induced glutamate-
cysteine ligase, glutathione peroxidase and gluta-
thione reductase protein expression in HCAE cells 
(p<0.05). Resveratrol increased the level of the glu-
tamate-cysteine ligase enzyme protein more than the 
level of the glutathione reductase protein. This may be 
due to the fact that the GSH/GSSG ratio is regulated 
by the glutamate-cysteine ligase mediated GSH bio-
synthesis.
The above results demonstrated that resveratrol 
prevented cell injury induced by hydrogen peroxide in 
HCAE cells. 
In the literature, the protective effect of resveratrol 
in different cells is shown by mRNA expression and/
or activities of the enzymes related to the glutathi-
one cycle in vitro. Rat aorta smooth muscle cells were 
preincubated with 25, 50 and 100 µM resveratrol for 
24, 48 and 72 hours and it was found to induce GSH 
levels and to increase the glutathione reductase, gluta-
thione peroxidase, superoxide dismutase, catalase and 
NAD(P)H:quinone oxireductase-1 activities. These 
data are thought to support the cardioprotective ef-
fects of resveratrol26. It was found that resveratrol 
induced antioxidant enzymes in rat cardiomyocytes 
(glutathione reductase, glutathione peroxidase, super-
oxide dismutase, catalase, glutathione-S-transferase 
and NAD(P)H:quinone oxireductase-1) and increased 
resistance to oxidative stress25.
We believe that it is logical to evaluate the mecha-
nism of the protective effects of resveratrol by ana-
lyzing the glutathione levels and glutamate-cysteine 
ligase, glutathione peroxidase and glutathione re-
ductase levels via nuclear factor E2-related factor 2 
(Nrf2) transcription in HCAE cells in vitro. 
Rubiolo et al.34 found that preincubation with 
resveratrol (25, 50 and 75 µM; 6, 24 and 48 hours) 
protected primary rat hepatocytes from oxidative 
stress by increasing the glutathione reductase, gluta-
thione peroxidase, superoxide dismutase, catalase and 
NAD(P)H:quinone oxireductase-1 and glutathione-
S-transferase activities. When compared with con-
trol cells, Nrf2 transcription factor was increased in 
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the cells pretreated with resveratrol (50 µM; 6, 24 
and 48 hours). The Nrf2 protein expression and in-
creased mRNA were correlated with high activities 
of phase II enzymes and antioxidants after preincu-
bation with resveratrol. Brito et al.16 showed that the 
cardioprotective effect of 50 µM resveratrol in bovine 
aorta endothelial cells (14 h incubation) was due to 
its regulatory role in cellular redox state (increasing 
intracellular GSH level and reducing peroxynitrite) 
besides the classical antioxidant effect. Resveratrol 
(50 µM, 30 minutes) reverses the total glutathione 
decrease due to hydrogen peroxide (100 µM H2O2; 
30 minutes) in primary cortical astrocyte cells35. Kode 
et al.14 showed the effects of tobacco extracts such as 
a decrease in GSH levels and GCLC activities to be 
reversed by 10 µM resveratrol. These results corre-
late with our data. Signal pathways of resveratrol to 
increase the antioxidant enzymes and phase II en-
zymes in human coronary artery endothelial cells are 
not clear. Further studies are needed to highlight the 
mechanisms of resveratrol in inducing protein expres-
sion of antioxidant enzymes. 
Recently, Nrf2 has been described. Nrf2 is a tran-
scription factor and under normal conditions, it is lo-
cated in the cytoplasm with the actin binding protein 
kelch-like ECH associating protein 1 (Keap 1). As the 
cell is exposed to oxidative stress or electrophilic com-
pounds, Nrf2 dissociates from its repressor protein 
(Keap 1), and after migrating to the nucleus, it binds 
to the antioxidant responsive elements and then acti-
vates phase II detoxifying and antioxidant genes14,36-38. 
Nrf2 regulates the expression of many antioxidant 
genes, including glutamate-cysteine ligase (GCL), 
hemeoxygenase-1 (HO-1) and NAD(P)H quinone 
oxidoreductase 1 (NQO1)39-42.
In conclusion, our in vitro study is the first one 
showing that resveratrol increases the glutathione 
level and glutamate-cysteine ligase, glutathione per-
oxidase-1 and glutathione reductase enzyme protein 
expressions in HCAE cells. This feature of resveratrol 
facilitates the understanding of some mechanisms of 
its cardioprotective effect and supports the develop-
ment of new therapeutic strategies. 
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Sažetak
ZAŠTITNI UČINCI RESVERATROLA OD OŠTEĆENJA LJUDSKIH ENDOTELNIH STANICA 
KORONARNE ARTERIJE IZAZVANOG VODIKOVIM PEROKSIDOM IN VITRO
O. Sayin, N. Arslan i G. Guner 
Oksidativni stres definira se kao neravnoteža između nastanka i razgradnje reaktivnih kisikovih vrsta. Cilj ove studije 
bio je istražiti može li resveratrol zaštititi ljudske endotelne stanice od oštećenja vodikovim peroksidom in vitro. U ovoj in 
vitro studiji na endotelnim stanicama koronarne arterije učinci resveratrola na sadržaj glutationa određeni su visokotlač-
nom tekućinskom kromatografijom. Učinci resveratrola na ekspresiju proteina enzima glutamat cistein ligaze, glutation 
peroksidaze-1 i glutation reduktaze određeni su metodom Western blot. Resveratrol je statistički značajno povećao sadržaj 
reduciranog glutationa (p<0,05). Resveratrol je povećao i ekspresiju proteina enzima glutamat cistein ligaze, glutation pe-
roksidaze-1 i glutation reduktaze (p<0,05). Svi dobiveni rezultati potvrđuju da resveratrol ima zaštitni učinak od oštećenja 
endotelnih stanica koronarne arterije. Rezultati ove studije daju smjernice prema novim terapijskim pristupima koji bi se 
rabili za zaštitu od oksidativnog stresa koji se razvija u bolestima krvožilnog sustava.
Ključne riječi: Resveratrol; Ljudske endotelne stanice koronarne arterije; Oksidativno oštećenje

